Stockscreener 앱 받기
432.66
1.70%
7.24
전일 마감가:
$425.42
열려 있는:
$426.86
하루 거래량:
705.95K
Relative Volume:
1.03
시가총액:
$19.52B
수익:
$2.99B
순이익/손실:
$1.21B
주가수익비율:
17.26
EPS:
25.06
순현금흐름:
$1.13B
1주 성능:
+3.61%
1개월 성능:
+39.92%
6개월 성능:
+39.20%
1년 성능:
+20.95%
1일 변동 폭
$422.99
$433.57
1주일 범위
$412.96
$442.01
52주 변동 폭
$266.98
$442.01
유나이티드 테라퓨틱스 Stock (UTHR) Company Profile
명칭
United Therapeutics Corp
전화
(301) 608-9292
주소
1000 SPRING ST, SILVER SPRING, MD
UTHR을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
UTHR
United Therapeutics Corp
|
432.66 | 19.24B | 2.99B | 1.21B | 1.13B | 25.06 |
|
ZTS
Zoetis Inc
|
143.50 | 62.55B | 9.39B | 2.62B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.74 | 46.27B | 29.96B | 957.25M | 4.77B | 0.304 |
|
HLN
Haleon Plc Adr
|
8.82 | 38.87B | 14.26B | 1.98B | 2.47B | 0.4347 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
18.34 | 21.06B | 16.70B | -157.13M | 1.19B | -0.155 |
유나이티드 테라퓨틱스 Stock (UTHR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-26 | 개시 | RBC Capital Mkts | Outperform |
| 2025-06-02 | 개시 | Cantor Fitzgerald | Overweight |
| 2025-04-25 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2025-04-21 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2024-07-11 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2024-02-12 | 업그레이드 | Goldman | Sell → Neutral |
| 2024-02-05 | 개시 | Leerink Partners | Outperform |
| 2023-12-08 | 개시 | Wells Fargo | Overweight |
| 2022-12-06 | 개시 | UBS | Buy |
| 2022-12-05 | 개시 | Goldman | Sell |
| 2022-10-11 | 개시 | Morgan Stanley | Overweight |
| 2022-09-20 | 재확인 | BofA Securities | Underperform |
| 2022-09-19 | 재개 | Wedbush | Outperform |
| 2022-02-11 | 개시 | BTIG Research | Neutral |
| 2021-07-14 | 업그레이드 | Argus | Hold → Buy |
| 2021-04-26 | 재개 | Credit Suisse | Outperform |
| 2021-02-01 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2020-09-14 | 재개 | JP Morgan | Overweight |
| 2020-06-25 | 재확인 | H.C. Wainwright | Neutral |
| 2020-03-10 | 업그레이드 | Jefferies | Hold → Buy |
| 2020-02-27 | 업그레이드 | Cowen | Market Perform → Outperform |
| 2020-01-31 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2019-12-03 | 개시 | BofA/Merrill | Underperform |
| 2019-08-01 | 업그레이드 | Jefferies | Underperform → Hold |
| 2019-08-01 | 업그레이드 | Ladenburg Thalmann | Neutral → Buy |
| 2019-07-01 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2019-05-17 | 업그레이드 | UBS | Sell → Neutral |
| 2019-05-09 | 업그레이드 | Credit Suisse | Underperform → Neutral |
| 2018-10-12 | 업그레이드 | Standpoint Research | Hold → Buy |
| 2018-08-08 | 다운그레이드 | Credit Suisse | Neutral → Underperform |
| 2018-04-03 | 업그레이드 | Credit Suisse | Underperform → Neutral |
| 2018-02-22 | 재확인 | Barclays | Underweight |
| 2018-01-18 | 재개 | Credit Suisse | Underperform |
| 2017-12-27 | 재확인 | Wedbush | Outperform |
| 2017-04-27 | 재확인 | Wedbush | Outperform |
| 2017-03-30 | 개시 | UBS | Sell |
| 2017-03-16 | 개시 | Credit Suisse | Underperform |
모두보기
유나이티드 테라퓨틱스 주식(UTHR)의 최신 뉴스
RBC Capital Initiates Coverage on United Therapeutics (UTHR) wit - GuruFocus
This United Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday - Benzinga
Sowell Financial Services LLC Invests $333,000 in United Therapeutics Corporation $UTHR - MarketBeat
RBC Capital initiates United Therapeutics stock with Outperform rating - Investing.com
United Therapeutics Rides Tyvaso Wins To Major Gains - Finimize
Martine Rothblatt Sells 4,000 Shares of United Therapeutics (NASDAQ:UTHR) Stock - MarketBeat
Rothblatt, United Therapeutics CEO, sells $3.4m in UTHR stock By Investing.com - Investing.com Nigeria
Insider Sell: Christopher Causey Sells 1,000 Shares of United Th - GuruFocus
Rothblatt, United Therapeutics CEO, sells $3.4m in UTHR stock - Investing.com India
United Therapeutics Corp. Hits New 52-Week High of $442.01 - Markets Mojo
United Therapeutics Corporation $UTHR Shares Sold by Ruffer LLP - MarketBeat
United Therapeutics Corp. Hits New 52-Week High of $438.26 - Markets Mojo
Are Robust Financials Driving The Recent Rally In United Therapeutics Corporation's (NASDAQ:UTHR) Stock? - 富途牛牛
Insider Selling: United Therapeutics (NASDAQ:UTHR) COO Sells 22,500 Shares of Stock - MarketBeat
Wedge Capital Management L L P NC Sells 11,432 Shares of United Therapeutics Corporation $UTHR - MarketBeat
Assenagon Asset Management S.A. Reduces Holdings in United Therapeutics Corporation $UTHR - MarketBeat
United Therapeutics stock reaches all-time high at $436.99 By Investing.com - Investing.com Australia
United Therapeutics stock reaches all-time high at $436.99 - Investing.com
United Therapeutics (NASDAQ:UTHR) Hits New 1-Year HighWhat's Next? - MarketBeat
United Therapeutics’ Surge: Is Now the Time? - StocksToTrade
Pallas Capital Advisors LLC Purchases 693 Shares of United Therapeutics Corporation $UTHR - MarketBeat
United Therapeutics Corp. Forms Golden Cross, Signals Bullish Breakout Ahead - Markets Mojo
United Therapeutics (NASDAQ:UTHR) CEO Sells $1,669,200.00 in Stock - MarketBeat
United Therapeutics (NASDAQ:UTHR) CEO Martine A. Rothblatt Sells 4,000 Shares - MarketBeat
United Therapeutics (NASDAQ:UTHR) Director Sells $747,774.00 in Stock - MarketBeat
United Therapeutics Corporation $UTHR Shares Sold by Livforsakringsbolaget Skandia Omsesidigt - MarketBeat
United Therapeutics (NASDAQ:UTHR) EVP Sells $4,467,870.00 in Stock - MarketBeat
Signal Advisors Wealth LLC Purchases Shares of 5,339 United Therapeutics Corporation $UTHR - MarketBeat
Positive TETON-2 Phase 3 Results Could Be a Game Changer for United Therapeutics (UTHR) - Sahm
Balefire LLC Acquires Shares of 1,307 United Therapeutics Corporation $UTHR - MarketBeat
Martine A. Rothblatt Sells 4,000 Shares of United Therapeutics (NASDAQ:UTHR) Stock - MarketBeat
Voya Investment Management LLC Boosts Holdings in United Therapeutics Corporation $UTHR - MarketBeat
Olian Judy D., director at United Therapeutics, sells $747k in stock By Investing.com - Investing.com South Africa
Performance Recap: Should I hold or sell United Therapeutics Corporation nowJuly 2025 Chart Watch & Real-Time Stock Price Movement Reports - khodrobank.com
Swing Trade: Is United Therapeutics Corporation stock influenced by commodity prices2025 Winners & Losers & Safe Capital Growth Tips - خودرو بانک
Olian Judy D., director at United Therapeutics, sells $747k in stock - Investing.com India
Insider Sell: Judy Olian Sells Shares of United Therapeutics Cor - GuruFocus
United Therapeutics (NASDAQ:UTHR) CEO Martine Rothblatt Sells 4,000 Shares - MarketBeat
United Therapeutics' TETON-2 Trial Shows Success in IPF Treatment | UTHR Stock News - Stock Titan
Published on: 2025-09-19 10:52:45 - خودرو بانک
Integrated Wealth Concepts LLC Sells 7,962 Shares of United Therapeutics Corporation $UTHR - MarketBeat
Aug Weekly: How cyclical is PG&E Corporation Preferred Security’s revenue stream2025 AllTime Highs & AI Powered Market Entry Strategies - khodrobank.com
United Therapeutics president Michael Benkowitz sells shares worth $3.65m - MSN
United Therapeutics president sells shares worth $3.7 million - MSN
Buybacks Report: Is United Therapeutics Corporation affected by consumer sentimentRisk Management & Verified Entry Point Detection - خودرو بانک
United Therapeutics Corporation $UTHR Shares Acquired by Ashton Thomas Private Wealth LLC - MarketBeat
Acadian Asset Management LLC Has $55.22 Million Stock Holdings in United Therapeutics Corporation $UTHR - MarketBeat
Fred Alger Management LLC Takes Position in United Therapeutics Corporation $UTHR - MarketBeat
United Therapeutics (NASDAQ:UTHR) Director Jan Malcolm Sells 700 Shares - MarketBeat
United Therapeutics (NASDAQ:UTHR) COO Michael Benkowitz Sells 5,000 Shares - MarketBeat
Insider Selling: United Therapeutics (NASDAQ:UTHR) COO Sells 11,375 Shares of Stock - MarketBeat
유나이티드 테라퓨틱스 (UTHR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
유나이티드 테라퓨틱스 주식 (UTHR) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| CAUSEY CHRISTOPHER | Director |
Sep 24 '25 |
Option Exercise |
119.76 |
1,000 |
119,760 |
5,865 |
| CAUSEY CHRISTOPHER | Director |
Sep 24 '25 |
Sale |
440.00 |
1,000 |
440,000 |
4,865 |
| ROTHBLATT MARTINE A | Chairperson & CEO |
Sep 23 '25 |
Option Exercise |
120.26 |
4,000 |
481,040 |
4,130 |
| ROTHBLATT MARTINE A | Chairperson & CEO |
Sep 24 '25 |
Option Exercise |
120.26 |
4,000 |
481,040 |
4,130 |
| ROTHBLATT MARTINE A | Chairperson & CEO |
Sep 24 '25 |
Sale |
434.12 |
4,000 |
1,736,489 |
130 |
| ROTHBLATT MARTINE A | Chairperson & CEO |
Sep 23 '25 |
Sale |
418.15 |
4,000 |
1,672,593 |
130 |
0.11%
0.79%
자본화:
|
볼륨(24시간):